By A Mystery Man Writer
(HealthDay)—For older women with estrogen receptor (ER)-positive ductal carcinoma in situ (DCIS), initiation of aromatase inhibitors (AIs) and adherence to treatment are low, according to a study published online Oct. 25 in Cancer.
Impact of Endocrine Therapy Adherence on Outcomes in Elderly Women with Early-Stage Breast Cancer Undergoing Lumpectomy Without Radiotherapy
Cancers, Free Full-Text
Frontiers Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer
Cancers, Free Full-Text
PDF) Identifying determinants of adherence to adjuvant endocrine therapy following breast cancer: A systematic review of reviews
Arthralgia in Breast Cancer Survivors: An Integrative Review of Endocrine Therapy
PDF) Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer
Current Oncology, Free Full-Text
Breast Cancer in Older Women